Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PC | P11498 | 7/20 | 0.88 |
| ▸ | F3 | P13726 | 3/20 | 0.60 |
| ▸ | XDH | P47989 | 1/20 | 0.53 |
| ▸ | GLS | O94925 | 1/20 | 0.49 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.48 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30543004 | 0.94 | PC (1.00) | PCF3XDHGLSPTGS1 | |
| SCHEMBL25817580 | 0.94 | PC (1.00) | PCF3XDHGLSPTGS1 | |
| SCHEMBL25993869 | 0.94 | PC (1.00) | PCF3XDHGLSPTGS1 | |
| SCHEMBL23983782 | 0.94 | PC (1.00) | PCF3XDHGLSPTGS1 | |
| SCHEMBL22567668 | 0.94 | PC (1.00) | PCF3XDHGLSPTGS1 | |
| SCHEMBL23983781 | 0.94 | PC (1.00) | PCF3XDHGLSPTGS1 | |
| SCHEMBL22145063 | 0.91 | PC (0.73) | PCF3XDHPTGS1PTGS2 | |
| SCHEMBL25817542 | 0.91 | PC (0.95) | PCF3XDHGLSPTGS1 | |
| SCHEMBL31256542 | 0.90 | PC (0.92) | PCF3XDHGLSPTGS1 | |
| SCHEMBL25993944 | 0.89 | PC (0.88) | PCF3XDHPTGS1PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11351184-B2 | Preparation of Pulsatilla saponin B4 for injection | LIU QI (CN) | 2022-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11351184-B2 | Preparation of Pulsatilla saponin B4 for injection | ATP6V1B1, VIP, F5 | PC 1523/4885F3 58/4885XDH 3172/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.